Determination of HIV-1 circular DNA as a surrogate marker for residual virus replication in patients with undetectable virus loads.
Hauber
I
I
Institute for Clinical and Molecular Virology, Erlangen, Germany.
Harrer
T
T
Löw
P
P
Schmitt
M
M
Schwingel
E
E
Hauber
J
J
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D004270:DNA, Circular / Q000032:analysis*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000821:virology; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction / Q000379:methods; D012367:RNA, Viral / Q000097:blood; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019562:Viral Load; D014779:Virus Replication
D019380:Anti-HIV Agents; D015415:Biomarkers; D004270:DNA, Circular; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors